poisar

Stocks · News reference

Stratasys, Limbitless Solution Expand 12-Year Partnership Over 3D-Printed Prosthetic Devices

Aug 18, 2026, 12:16 PMBenzinga Newsdesk

Stratasys Ltd. (NASDAQ:SSYS), a global leader in additive manufacturing solutions, and Limbitless Solutions, a nonprofit research facility at the University of Central Florida dedicated to empowering children through

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SSYS
Source
benzinga
Observed
Aug 18, 2026, 12:16 PM
Checked
Aug 18, 2026, 12:16 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 11:51 AMNa

    Correction: Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

    The global bioprinting market is projected to grow from $2.1 billion in 2024 to $5.1 billion by 2030 at a 16.1% CAGR, driven by regenerative medicine demand, pharmaceutical adoption for drug discovery, reduced animal testing, and AI integration. North America leads with 38% market share, while emerging technologies like 4D bioprinting and organ-on-chip devices expand market boundaries.

    Read original at globenewswire-inc
    DDDMKKGYSSYSBCCOY